Getting Results From Big Data Depends On Trust Between Stakeholders
Manufacturers, payers and providers will need to learn how to trust each other’s data sources if the benefits of the big datasets of real-world evidence are to be realized, pharmaceutical execs say.
You may also be interested in...
Richard Platt of PCORI’s National Patient-Centered Clinical Research Network discusses the future of comparative effectiveness research using big data during an expert roundtable session hosted by NEHI.
Pharmaceutical companies are beginning to leverage big data to become more integrated into health care delivery, looking to care coordination and other “services adjacent to medicines,” IBM’s John Piccone reports.
A new study by IMS Health shows payers globally are making more drug reimbursement decisions based on real-world evidence – including 25% of more than 100 identified case studies using biopharma industry-generated data.